Aussie Court Grants Three-Month Delay In Ban Of Aspen Painkillers
This article was originally published in PharmAsia News
Executive Summary
South Africa’s Aspen Pharma won a three-month Australian reprieve of a ban on a pair of questionable painkillers the Therapeutic Goods Administration wants off the market because of alleged heart problems.